Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 06.15.2020
Just as a fruit needs time to ripen, so a candidate vaccine needs time to progress to an approval by the U.S. Food and Drug Administration (FDA). On December 19, 2019, the world’s first vaccine for Ebola virus disease, Ervebo, received FDA approval. The development and evaluation of Ervebo spanned several decades, beginning in 1976, and involved multiple organizations, including the Defense......
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 03.19.2020
Sometimes, a U.S. Air Force C-17 Globemaster III airlifter can be just what the doctor ordered to help prevent the spread of Ebola virus disease. In August 2019, the Defense Threat Reduction Agency (DTRA) responded to a request from the Biomedical Advanced Research and Development Authority (BARDA) to assist in transporting a bulk quantity of the Ebola vaccine material from Germany to......
Story by Adam Lowe | Capability Program Executive Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND) | 12.20.2019
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical’s (JPM CBRN Medical) involvement with today’s U.S. Food and Drug Administration (FDA)-approval of the world’s first Ebola vaccine contributed to a leap forward in protecting both the warfighter and......
